Associate Professor Hongchao Pan
Hongchao Pan is a statistician and epidemiologist in the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU). He holds a PhD in astrophysics from University of Leicester and an MSc in epidemiology from London School of Hygiene & Tropical Medicine. Since joining CTSU in 1995, he has worked on number of large-scale randomised clinical trials (such as CAST, COMMIT/CCS2, ACST, ATLAS) and epidemiological studies.
His research interests include systemic treatments for early breast cancer, effect of obesity on breast cancer prognosis, and mortality from smoking. Dr Pan leads the meta-analysis of individual participant data of the breast cancer screening trials with mammography and the long-term follow-up of the British Doctors Study.
Anthracycline and taxane containing chemotherapy for early-stage operable breast cancer: meta-analyses of 100,000 women in 86 randomised trials
Taylor CAROLYN. et al, (2023), The Lancet
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
(2022), The Lancet, 399, 1941 - 1953
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
WHO Solidarity Trial Consortium None. et al, (2021), N Engl J Med, 384, 497 - 511
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
PAN H. and Peto R., (2020), MedRxiv
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.
Mappin-Kasirer B. et al, (2020), Neurology, 94, e2132 - e2138